BMKDF Stock Price, Chart, Stats & News

BioMark Diagnostics Inc.
Save
BioMark Diagnostics Inc. (BMKDF) does not currently pay a dividend.
45.17M
Market cap
–
Current P/E
–
Forward P/E
BMKDF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Diagnostics & Research
Industry
BioMark Diagnostics Inc. is an oncology-focused firm that develops sophisticated diagnostic tools for cancer. These solutions are designed to aid in the identification of the disease, its ongoing monitoring, and the assessment of initial therapeutic interventions. The company has a research partnership with the Icahn School of Medicine, under which they conduct clinical studies concentrating on the early detection of lung cancer.
Similar securities
Based on sector and market capitalization
Report issue





